Latest news on Novo Nordisk, a global healthcare company focused on diabetes care, obesity treatment, and other serious chronic diseases.

Novo Nordisk · Novo Nordisk, Eli Lilly could face downward pressure despite market dominance from potentially 16 new obesity drugs: See the names.

Latest news · 08 October 2024. Novo Nordisk launches new initiative to prevent childhood obesity in disadvantaged urban communities · 20 September 2024. Novo ...

This new finding about Ozempic and Wegovy could hurt Novo Nordisk's stock · Why Viking Therapeutics is thriving in the $150 billion weight loss drug market · Novo ...

6 сент. 2024 г. · Novo Nordisk's experimental weight loss pill showed significant results in its first trial. Quartz 3d. Pharma Ozempic · Amycretin · Novo ...

Novo Nordisk: Earnings trimmed as rivals seek to enter market. Obesity rates in the US have been rising steadily and Novo Nordisk and others are tapping into ...

Novo Nordisk (NVO) closed the most recent trading day at $117.81, moving -1.64% from the previous trading session. Zacks • yesterday.

Latest news · 08 October 2024. Novo Nordisk launches new initiative to prevent childhood obesity in disadvantaged urban communities · 20 September 2024. Novo ... Novo Nordisk · Latest news · Our medicines · Find a job

Novo Nordisk has a share of more than half of the global market for the class of drugs that treat diabetes and obesity.

Novo Nordisk A/S · Catalent to sell New Jersey facility October 14, 2024 · US FDA to reconsider decision barring compounded versions of Lilly weight loss drug ...